96 related articles for article (PubMed ID: 2534935)
1. Metabolic imaging of human brain tumors.
Wilson CB
Semin Neurol; 1989 Dec; 9(4):388-93. PubMed ID: 2534935
[No Abstract] [Full Text] [Related]
2. Brain imaging of glucose utilization in cerebral tumors.
Di Chiro G
Res Publ Assoc Res Nerv Ment Dis; 1985; 63():185-97. PubMed ID: 3875134
[No Abstract] [Full Text] [Related]
3. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
Di Chiro G
Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318
[No Abstract] [Full Text] [Related]
4. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M
Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854
[No Abstract] [Full Text] [Related]
5. Clarification of a fractional uptake concept.
Thie JA
J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
[No Abstract] [Full Text] [Related]
6. Relation between tissue nature and (18F) fluorodeoxyglucose kinetics evaluated by dynamic positron emission tomography in human brain tumors.
Yamaguchi T; Sasaki H; Ogawa T; Mineura K; Uemura K; Kanno I; Shishido F; Murakami M; Inugami A; Higano S
Acta Radiol Suppl; 1986; 369():415-8. PubMed ID: 2980513
[TBL] [Abstract][Full Text] [Related]
7. [Positron emission tomographic evaluations on hemodynamics and glucose metabolism of brain tumors and perifocal edematous tissues].
Mizukawa N; Hino A; Imahori Y; Tenjin H; Yano I; Yoshino E; Hirakawa K; Yamashita M; Oki F; Nakahashi H
No To Shinkei; 1989 Mar; 41(3):251-8. PubMed ID: 2787998
[TBL] [Abstract][Full Text] [Related]
8. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
9. Clinical application of PET for the evaluation of brain tumors.
Coleman RE; Hoffman JM; Hanson MW; Sostman HD; Schold SC
J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
[TBL] [Abstract][Full Text] [Related]
10. Neuroimaging of juvenile pilocytic astrocytomas: an enigma.
Fulham MJ; Melisi JW; Nishimiya J; Dwyer AJ; Di Chiro G
Radiology; 1993 Oct; 189(1):221-5. PubMed ID: 8372197
[TBL] [Abstract][Full Text] [Related]
11. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
[TBL] [Abstract][Full Text] [Related]
12. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
[TBL] [Abstract][Full Text] [Related]
13. The in vivo metabolic investigation of brain gliomas with positron emission tomography.
Derlon JM
Adv Tech Stand Neurosurg; 1998; 24():41-76. PubMed ID: 10050211
[No Abstract] [Full Text] [Related]
14. [Evaluation of brain tumors using positron emission tomography].
Schober O; Meyer GJ
Radiologe; 1992 Jun; 32(6):282-9. PubMed ID: 1322547
[TBL] [Abstract][Full Text] [Related]
15. Sequential computerized tomography and positron emission tomography studies in a patient with malignant glioma.
Alavi JB; Alavi A; Goldberg HI; Dann R; Hickey W; Reivich M
Nucl Med Commun; 1987 Jul; 8(7):457-68. PubMed ID: 2825089
[TBL] [Abstract][Full Text] [Related]
16. Effects of temporal sampling, glucose metabolic rates, and disruptions of the blood-brain barrier on the FDG model with and without a vascular compartment: studies in human brain tumors with PET.
Hawkins RA; Phelps ME; Huang SC
J Cereb Blood Flow Metab; 1986 Apr; 6(2):170-83. PubMed ID: 3485641
[TBL] [Abstract][Full Text] [Related]
17. Functional imaging using PET and SPECT in pediatric neurology.
Messa C; Grana C; Lucignani G; Fazio F
J Nucl Biol Med (1991); 1994 Mar; 38(1):85-8. PubMed ID: 8075181
[No Abstract] [Full Text] [Related]
18. Positron emission tomography (PET) and single-photon emission computed tomography (SPECT) of brain tumors.
Rozental JM
Neurol Clin; 1991 May; 9(2):287-305. PubMed ID: 1944100
[TBL] [Abstract][Full Text] [Related]
19. Optimal cutoff levels of F-18 fluorodeoxyglucose uptake in the differentiation of low-grade from high-grade brain tumors with PET.
Delbeke D; Meyerowitz C; Lapidus RL; Maciunas RJ; Jennings MT; Moots PL; Kessler RM
Radiology; 1995 Apr; 195(1):47-52. PubMed ID: 7892494
[TBL] [Abstract][Full Text] [Related]
20. Brain metastases from non-central nervous system tumors: evaluation with PET.
Griffeth LK; Rich KM; Dehdashti F; Simpson JR; Fusselman MJ; McGuire AH; Siegel BA
Radiology; 1993 Jan; 186(1):37-44. PubMed ID: 8416584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
